Abstract
Objectives
Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are common procedures for managing coronary artery disease (CAD); however, optimal methods of comparing post-procedure outcomes are unclear. We evaluated the reliability of Synergy between percutaneous coronary intervention with Taxus and cardiac surgery (SYNTAX) scores and investigated differences in long-term outcomes after CABG among groups with different SYNTAX scores.
Methods
According to patient selection criteria used in the SYNTAX trial, 368 patients who underwent isolated initial CABG between 2003 and 2014 at Kurashiki Central Hospital were stratified into three SYNTAX score I groups (low: < 23, intermediate: 23 to < 33, and high: ≥ 33) and three SYNTAX score II groups (low: < 30, intermediate: 30 to < 40, and high: ≥ 40). Group outcomes were compared. Overall 4-year mortality data for SYNTAX score II were compared with the cohort data.
Results
There were no significant differences in all-cause death, 10-year major adverse cardiac and cerebrovascular events (MACCEs), myocardial infarction, and stroke data in the SYNTAX score I groups. As SYNTAX score II increased, all-cause death and MACCEs rates rose significantly. Four-year mortality at our facility was 11.0 ± 1.7%, whereas that predicted by SYNTAX score II was 12.0 ± 11.1%. The predicted data were close to the clinical data, but not statistically significant, with an area under the curve of 0.769.
Conclusions
SYNTAX score II demonstrated reasonable predictive performance for outcomes after CABG, whereas SYNTAX score I did not. With SYNTAX score systems, treatment options should be discussed with a heart team to achieve better outcomes.
Similar content being viewed by others
References
Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg. 1968;5:334–9.
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–72.
Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomized, clinical SYNTAX trial. Lancet. 2013;381:629–38.
Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byme JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for diagnosis and management of patient with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiology and Interventions, and Society for Thoracic Surgeons. Circulation. 2014;130:1749–67.
Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61–8.
Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol. 2010;55:1093–101.
Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55:432–40.
Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011;57:538–45.
Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011;364:1718–27.
Farooq V, Van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381:639–50.
Marui A, Okabayashi H, Komiya T, Tanaka S, Furukawa Y, Kita T, et al. Benefits of off-pump coronary artery bypass grafting in high-risk patients. Circulation. 2012;126:S151–7.
Murzi M, Caputo M, Aresu G, Duggan S, Miceli A, Glauber M, et al. On-pump and off-pump coronary artery bypass grafting in patients with left main stem disease: a propensity score analysis. J Thorac Cardiovasc Surg. 2012;143:1382–8.
Cho Y, Shimura S, Aki A, Furuya H, Okada K, Ueda T. The SYNTAX score is correlated with long-term outcomes of coronary artery bypass grafting for complex coronary artery lesions. Interact Cardiovasc Thorac Surg. 2016;23:125–32.
Capodanno D, Miano M, Cincotta G, Caggegi A, Ruperto C, Bucalo R, et al. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J. 2010;159:103–9.
Farooq V, Brugaletta S, Serruys PW. Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention. Heart. 2011;97:1902–13.
Fukui T, Uchimuro T, Takanashi S. EuroSCORE II with SYNTAX score to assess risks of coronary artery bypass grafting outcomes. Eur J Cardiothorac Surg. 2015;47:66–71.
Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, et al. Coronary artery bypass graft surgery versus drug-eluting stent implantation for high-surgical-risk patients with left main or multivessel coronary artery disease. Eur J Cardiothorac Surg. 2017;15:943–9.
Gannot S, Fefer P, Kopel E, Kochkina K, Beigel R, Raanani E, et al. Higher SYNTAX score is not predictive of late mortality in “real-world” patients with multivessel coronary artery disease undergoing coronary artery bypass grafting. Isr Med Assoc J. 2014;16:764–7.
Campos CM, van Klaveren D, Iqbal J, Onuma Y, Zhang YJ, Garcia-Garcia HM, et al. Predictive performance of SYNTAX score II in patients with left main and multivessel coronary artery disease. Circ J. 2014;78:1942–9.
Sotomi Y, Cavalcante R, van Klaveren D, Ahn JM, Lee CW, de Winter RJ, et al. Individual long-term mortality prediction following either coronary stenting or bypass surgery in patients with multivessel and/or unprotected left main disease: an external validation of the syntax score II model in the 1,480 patients of best and precombat randomized trials. JACC Cardiovasc Interv. 2016;9:1564–72.
Xu B, Genereux P, Yang Y, Leon MB, Xu L, Quiao S, et al. Validation and comparison of the long–term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention. JACC Cardiovasc Interv. 2014;7:1128–37.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nonaka, M., Komiya, T., Shimamoto, T. et al. Comparison of clinical outcomes after coronary artery bypass grafting using stratified SYNTAX scores. Gen Thorac Cardiovasc Surg 68, 1270–1277 (2020). https://doi.org/10.1007/s11748-020-01361-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-020-01361-y